CCR6: a biomarker for Alzheimer's-like disease in a triple transgenic mouse model.

The inflammatory status of the brain in patients as well as animal models of Alzheimer's disease (AD) has been extensively studied. Accumulation of activated microglia producing tumor necrosis factor-α and monocyte chemotactic protein-1 contribute to the pathology of the disease. However, little is known about the changes in the spleen and associated peripheral immunity that might contribute to AD pathology. The goal of this study was to characterize phenotypic and functional changes in spleen, blood and brain cell populations that contribute to development of an AD-like disease in a triple transgenic (3xTg-AD) mouse model. The 3xTg-AD mice had increased percentages of brain Gr-1+ granulocytes, dendritic cells and macrophages, spleen and blood derived CD8+Ly6C+ memory T cells and CCR6+ B cells, as well as increased levels of secreted interleukin-6. Brain tissue from older 12 month old symptomatic 3xTg-AD female mice exhibited highly elevated mRNA expression of CCR6 compared to wild-type mice. Importantly, this pronounced increase in expression of CCR6 was also detected in brain and spleen tissue from pre-symptomatic 5--6 month old 3xTg-AD females and males. Our data demonstrate increased expression of CCR6 in the brain and peripheral immune organs of both pre-symptomatic and symptomatic 3xTg-AD mice, strongly suggesting an ongoing inflammatory process that precedes onset of clinical AD-like disease.

[1]  Masanori Kato,et al.  Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases , 2002, Journal of Neuroimmunology.

[2]  S. Barger,et al.  Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway , 2003, The Journal of Neuroscience.

[3]  C. Martínez-A,et al.  CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses. , 2005, Blood.

[4]  Sue-Jane Lin,et al.  Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation , 2007, The Journal of experimental medicine.

[5]  S. Lipton,et al.  Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. , 1999, Stroke.

[6]  P. Marrack,et al.  Identification of two major types of age-associated CD8 clonal expansions with highly divergent properties , 2008, Proceedings of the National Academy of Sciences.

[7]  I. Messaoudi,et al.  Age-Related CD8+ T Cell Clonal Expansions Express Elevated Levels of CD122 and CD127 and Display Defects in Perceiving Homeostatic Signals1 , 2006, The Journal of Immunology.

[8]  G. Annoni,et al.  Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? , 2000, Journal of Neuroimmunology.

[9]  K. Pennypacker,et al.  The spleen contributes to stroke‐induced neurodegeneration , 2008, Journal of neuroscience research.

[10]  Soo‐Young Choi,et al.  Oligonucleotide-based Analysis of Differentially Expressed Genes in Hippocampus of Transgenic Mice Expressing NSE-controlled APPsw , 2006, Neurochemical Research.

[11]  L. Frölich,et al.  Apoptosis of CD4+ T and natural killer cells in Alzheimer's disease. , 2006, Pharmacopsychiatry.

[12]  M. Donia,et al.  Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells. , 2009, Journal of autoimmunity.

[13]  F. LaFerla,et al.  Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice , 2005, Journal of Neuroinflammation.

[14]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[15]  F. LaFerla,et al.  Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. , 2008, The American journal of pathology.

[16]  U. Hanisch,et al.  Microglia as a source and target of cytokines , 2002, Glia.

[17]  R. Rabin,et al.  CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.

[18]  Pawan Kumar,et al.  Role of Macrophage Inflammatory Protein-3α and Its Ligand CCR6 in Rheumatoid Arthritis , 2003, Laboratory Investigation.

[19]  S. Lira,et al.  Attenuation of Allergen-Induced Responses in CCR6−/− Mice Is Dependent upon Altered Pulmonary T Lymphocyte Activation , 2005, The Journal of Immunology.

[20]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[21]  Jae Woong Lee,et al.  Journal of Neuroinflammation Neuro-inflammation Induced by Lipopolysaccharide Causes Cognitive Impairment through Enhancement of Beta-amyloid Generation , 2022 .

[22]  J. Bluestone,et al.  Ly-6C is a marker of memory CD8+ T cells. , 1995, Journal of immunology.

[23]  R. Tibshirani,et al.  Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.

[24]  D. Ethell,et al.  Aβ-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS , 2009, Neurobiology of Disease.

[25]  P. Grammas,et al.  Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease , 2001, Neurobiology of Aging.

[26]  R. Kayed,et al.  Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease , 2005, Journal of Neuroinflammation.

[27]  M. Weinand,et al.  Amyloid-β Induces Chemokine Secretion and Monocyte Migration across a Human Blood-Brain Barrier Model , 1998, Molecular medicine.

[28]  E. Scarpini,et al.  Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid[25–35] , 1999, Journal of Neuroimmunology.

[29]  C. Caltagirone,et al.  Increased pro-inflammatory response by dendritic cells from patients with Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[30]  S. Barger.  Vascular consequences of passive Aβ immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough? , 2005, Journal of Neuroinflammation.

[31]  B. Rocha,et al.  The Tower of Babel of CD8+ T‐cell memory: known facts, deserted roads, muddy waters, and possible dead ends , 2006, Immunological reviews.

[32]  D. Flaherty,et al.  Age dependent increase in early resistance of mice to Mycobacterium tuberculosis is associated with an increase in CD8 T cells that are capable of antigen independent IFN-γ production , 2006, Experimental Gerontology.

[33]  P. Mcgeer,et al.  Inflammation in transgenic mouse models of neurodegenerative disorders. , 2010, Biochimica et biophysica acta.

[34]  H. Offner,et al.  Male SJL mice do not relapse after induction of EAE with PLP 139–151 , 1996, Journal of neuroscience research.

[35]  L. Frölich,et al.  Increased T-cell Reactivity and Elevated Levels of CD8+ Memory T-cells in Alzheimer’s Disease-patients and T-cell Hyporeactivity in an Alzheimer’s Disease-mouse Model: Implications for Immunotherapy , 2007, NeuroMolecular Medicine.

[36]  C. Lyketsos,et al.  IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease , 2009, International Psychogeriatrics.

[37]  Paul S. Aisen,et al.  Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model , 2008, Brain Research.

[38]  F. LaFerla,et al.  Profile for Amyloid-β and Tau Expression in Primary Cortical Cultures from 3xTg-AD Mice , 2010, Cellular and Molecular Neurobiology.

[39]  D. Ethell,et al.  Aβ-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice , 2006, Neurobiology of Disease.

[40]  O. Simell,et al.  Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Jalkanen,et al.  Ly6C Induces Clustering of LFA-1 (CD11a/CD18) and Is Involved in Subtype-Specific Adhesion of CD8 T Cells 1 , 2003, The Journal of Immunology.

[42]  T. Schumacher,et al.  Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis , 2009, Proceedings of the National Academy of Sciences.

[43]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[44]  F. Barone,et al.  Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue , 1994, Brain Research Bulletin.

[45]  K. Moore,et al.  CD36 Mediates the Innate Host Response to β-Amyloid , 2003, The Journal of experimental medicine.

[46]  S. Lira,et al.  CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC , 2010, European journal of immunology.